About Valar Labs
Valar Labs is a company based in Palo Alto (United States) founded in 2021 by Pranav Rajpurkar, Anirudh Joshi, Viswesh Krishna, and Damir Vrabac. Valar Labs has raised $26.15 million across 2 funding rounds from investors including Pear VC, DCVC and Andreessen Horowitz. Valar Labs offers products and services including Vesta and AI Diagnostics. Valar Labs operates in a competitive market with competitors including NEOGAP, Azra, Oncora, Cambridge Cancer Genomics and Cyted, among others.
- Headquarter Palo Alto, United States
- Founders Pranav Rajpurkar, Anirudh Joshi, Viswesh Krishna, Damir Vrabac
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Valar Labs, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.15 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series A
May 30, 2024
-
Investors
Pear VC
& 18 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Valar Labs
Valar Labs offers a comprehensive portfolio of products and services, including Vesta and AI Diagnostics.
Predicts bladder cancer treatment responses using AI on histology.
Provides insights into tumor microenvironments for therapy selection.
People of Valar Labs
Unlock access to complete
Funding Insights of Valar Labs
Valar Labs has successfully raised a total of $26.15M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Valar Labs
Valar Labs has secured backing from 19 investors, including venture fund and angel investors. Prominent investors backing the company include Pear VC, DCVC and Andreessen Horowitz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Seed & early stage VC firm investing the US
|
Locked | Locked | Locked |
Investor details for Valar Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Valar Labs
Investment portfolio details for Valar Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Valar Labs
Detailed financials for Valar Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Valar Labs Comparisons
Peer comparison for Valar Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Valar Labs
Valar Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NEOGAP, Azra, Oncora, Cambridge Cancer Genomics and Cyted, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radiopharmaceuticals for cancer treatment are developed using advanced technologies.
|
|
| Locked | Locked | Locked |
Oncology workflows are automated through AI and machine learning.
|
|
| Locked | Locked | Locked |
AI-based clinical data analysis and decision support tool for oncologists
|
|
| Locked | Locked | Locked |
Developer of AI-based precision medicine tools for oncologists
|
|
| Locked | Locked | Locked |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
Detailed competitors of Valar Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Valar Labs
Complete news archive for Valar Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valar Labs
Valar Labs was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Valar Labs is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Anirudh Joshi is the current CEO of Valar Labs. They have also founded this company.
Valar Labs is a funded company, having raised a total of $26.15M across 2 funding rounds to date.
Valar Labs was founded in 2021 and is headquartered in Palo Alto, United States. Operations focus on the health technology sector, where AI-driven software is developed to support oncology treatment planning and management. Features include analysis of patient characteristics, data processing, and disease diagnosis assistance for healthcare providers. The tool aids in decision-making processes within clinical settings.
Valar Labs's top competitors include NEOGAP, Azra and Cambridge Cancer Genomics.
Valar Labs offers Vesta and AI Diagnostics.
Valar Labs has 19 investors. Key investors include Pear VC, DCVC, Andreessen Horowitz, Dave King, and Devin Carty.